Literature DB >> 21434701

Development of single-cycle replicable human immunodeficiency virus 1 mutants.

R Zabihollahi1, S M Sadat, R Vahabpour, M R Aghasadeghi, A Memarnejadian, T Ghazanfari, M Salehi, A Rezaei, K Azadmanesh.   

Abstract

Non-infectious but antigenic human immunodeficiency virus 1 (HIV-1) particles are essential tool for the research on many topics associated with this virus. Here we report the construction of plasmid containing the HIV-1 genome mutated in the pol gene, which was co-transfected with plasmids expressing the pol gene products reverse transcriptase (RT) and integrase (IN), and the glycoprotein G of vesicular stomatitis virus (VSV-G). The virions produced in HEK 293 T cells were antigenic, but able to replicate only for one cycle, e.g. first generation single-cycle replicable (SCR) virions. The presence of VSV-G in the envelope of these virions had to ensure a wider spectrum of susceptible cell types for the replication of SCR. Replication of the first generation SCR virions in HEK 293T, MT-2, and mouse spleen cells was examined by p24-capture ELISA, syncytium formation assay, and electron microscopy (EM). HEK 293T and MT-2 cell lines showed a similar replication capacity, while primary cultures of mouse spleen cells were much less effective. The infection of MT-2 cells with the first generation of SCR virions yielded the second generation SCR virions, which were non-infectious. Summing up, the HIV-1 SCR virions represent the useful tool for HIV-1 research facilitating a better biological safety. Moreover, considering their antigenic composition and limited replication, SCR virions may be a promising candidate for the vaccine studies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21434701     DOI: 10.4149/av_2011_01_15

Source DB:  PubMed          Journal:  Acta Virol        ISSN: 0001-723X            Impact factor:   1.162


  8 in total

1.  Toward the development of a single-round infection assay based on EGFP reporting for anti-HIV-1 drug discovery.

Authors:  Mahdieh Soezi; Arash Memarnejadian; Saeed Aminzadeh; Rezvan Zabihollahi; Seyed Mehdi Sadat; Safieh Amini; Soheila Hekmat; Mohammad Reza Aghasadeghi
Journal:  Rep Biochem Mol Biol       Date:  2015-10

2.  Novel 2-(Diphenylmethylidene) Malonic Acid Derivatives as Anti-HIV Agents: Molecular Modeling, Synthesis and Biological Evaluation.

Authors:  Mehrnaz Lotfaliei; Elham Rezaee; Zahra Hajimahdi; Mohammad Mahboubi Rabbani; Rezvan Zabihollahi; Mohammad Reza Aghasadeghi; Sayyed Abbas Tabatabai
Journal:  Iran J Pharm Res       Date:  2021-12-14       Impact factor: 1.962

3.  Design of Small Molecules with HIV Fusion Inhibitory Property Based on Gp41 Interaction Assay.

Authors:  Soroush Sardari; Kayhan Azadmanesh; Fereidoun Mahboudi; Asghar Davood; Ruhollah Vahabpour; Rezvan Zabihollahi; Hosna Gomari
Journal:  Avicenna J Med Biotechnol       Date:  2013-04

4.  Inhibitory Activity of Avicennia marina, a Medicinal Plant in Persian Folk Medicine, against HIV and HSV.

Authors:  Rahele Namazi; Rezvan Zabihollahi; Mandana Behbahani; Abbas Rezaei
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

5.  Venom Components of Iranian Scorpion Hemiscorpius lepturus Inhibit the Growth and Replication of Human Immunodeficiency Virus 1 (HIV-1).

Authors:  Rezvan Zabihollahi; Kamran Pooshang Bagheri; Zohreh Keshavarz; Fatemeh Motevalli; Golnaz Bahramali; Seyed Davar Siadat; Seyed Bahman Momen; Delavar Shahbazzadeh; Mohammad Reza Aghasadeghi
Journal:  Iran Biomed J       Date:  2016-09-04

6.  Triterpene Constituents of Euphorbia Erythradenia Bioss. and their Anti-HIV Activity.

Authors:  Abdul Majid Ayatollahi; Seyed Mohammad Zarei; Arash Memarnejadian; Mustafa Ghanadian; Mohammad Heydarian Moghadam; Farzad Kobarfard
Journal:  Iran J Pharm Res       Date:  2016       Impact factor: 1.696

7.  The in vitro anti-viral potential of Setarud (IMOD™), a commercial herbal medicine with protective activity against acquired immune deficiency syndrome in clinical trials.

Authors:  Rezvan Zabihollahi; Rahele Namazi; Mohammad Reze Aghasadeghi; Azar Farhang Esfahani; Seyed Mehdi Sadat; Mohammad Hossein Modarressi
Journal:  Indian J Pharmacol       Date:  2012 Jul-Aug       Impact factor: 1.200

8.  Inhibition of HIV and HSV infection by vaginal lactobacilli in vitro and in vivo.

Authors:  Rezvan Zabihollahi; Elahe Motevaseli; Seyed Mehdi Sadat; Ali Reza Azizi-Saraji; Sogol Asaadi-Dalaie; Mohammad Hossein Modarressi
Journal:  Daru       Date:  2012-10-15       Impact factor: 3.117

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.